978
H. Zhao et al.
argon for 10 min. InCl3 (57 mg, 0.26 mmol) was added, and the
reaction was allowed to proceed for 30 min. The reaction was
quenched with NaOH powder (800 mg, 20 mmol). The mixture
was stirred for 45 min and then filtered. Excess pyrrole was
removed by distilling under reduced pressure, and the resulting
yellow solid was treated with hexanes (10 mL). The solvent was
removed under reduced pressure, and the residue was purified
by column chromatography on silica gel (eluted with hexane/
CH2Cl2/ethyl acetate ¼ 7 : 2 : 1) to give compound 3e as a pale
yellow solid (839 mg, 89 %). M.p. 108–1118C. 1H NMR
(400 MHz, CDCl3) d 8.31 (brs, 4H), 6.90 (s, 2H), 6.78 (s, 2H),
6.68 (s, 4H), 6.14 (m, 4H), 5.97 (s, 4H), 5.71 (s, 2H), 3.82
(t, J ¼ 6.3 Hz, 4H), 3.75 (t, J ¼ 6.2 Hz, 4H), 1.63–1.46 (m, 8H),
1.29 (m, 8H), 0.86 (m, 12H); 13C NMR (100 MHz, CDCl3)
d 150.87, 150.08, 132.83, 131.06, 117.45, 116.69, 116.65,
115.59, 108.37, 106.76, 69.55, 69.53, 39.34, 31.70, 31.68,
31.65, 19.38, 19.35, 19.30, 13.93; m/z (MALDI-TOF)
730.448; [MþH]þ requires 730.446.
1,4-Bis(4-dipyrromethylphenoxy)benzene (3j)
Compound 1j (550 mg, 1.73 mmol) was dissolved in dry
pyrrole (20 mL, 0.30 mol) and flushed with argon for 10 min.
InCl3 (76 mg, 0.35 mmol) was added, and the reaction was
allowed to proceed for 30 min before quenching with powdered
NaOH (0.8 g, 20 mmol). The mixture was stirred for 45 min and
then filtered. Excess pyrrole was removed by distillation under
reduced pressure, and the resulting yellow solid was treated with
hexanes (10 mL). The solvent was removed under reduced
pressure, and the residue was purified by column chromatogra-
phy on silica gel (eluted with CH2Cl2) to afford a pale yellow
solid (0.80 g, 84 %). M.p. 63–668C. 1H NMR (400 MHz, CDCl3)
d 7.96 (brs, 4H), 7.17 (d, J ¼ 8.5 Hz, 4H), 6.98 (d, J ¼ 4.3 Hz,
4H), 6.93 (d, J ¼ 8.5 Hz, 4H), 6.71 (d, J ¼ 1.2 Hz, 4H), 6.16
(d, J ¼ 2.7 Hz, 4H), 5.92 (s, 4H), 5.46 (s, 2H); 13C NMR
(100 MHz, CDCl3) d 156.59, 152.63, 136.82, 132.54, 129.59,
120.40, 118.22, 117.23, 108.37, 107.18, 43.22; m/z (MALDI-
TOF) 549.229; [MþH]þ requires 550.237.
2,5-Dibutoxy-1,4-bis[2,5-bis(butoxy)-4-(dipyrromethan-
5-yl)phenyl]benzene (3f)
2,5-Bis(octyloxy)-1,4-bis{[(2,5-bis(butoxy)-4-
(dipyrromethan-5-yl)]phenylenevinylene} benzene (3h)
Compound 1f (1.8 g, 2.5 mmol) was dissolved in dry
pyrrole (28 mL, 0.4 mol) and flushed with argon for 10 min.
InCl3 (111 mg, 0.5 mmol) was added, and the reaction was
allowed to proceed for 30 min before quenching with NaOH
powder (800 mg, 20 mmol). The mixture was stirred for
45 min and then filtered. Excess pyrrole was removed by
distillation under reduced pressure, and the resulting yellow
solid was treated with hexanes (10 mL). The solvent was
removed under reduced pressure, and the residue was puri-
fied by column chromatography on silica gel (eluted with
hexane/CH2Cl2/ethyl acetate ¼ 7 : 2 : 1) to give the compound
3f as a pale yellow solid (2.1 g, yield 88 %). M.p. 174–1778C;
1H NMR (400 MHz, CDCl3) d 8.31 (s, 4H), 6.98 (s, 2H), 6.95
(s, 2H), 6.80 (s, 2H), 6.69 (s, 4H), 6.15 (d, J ¼ 2.3 Hz, 4H),
5.98 (s, 2H), 5.73 (s, 1H), 3.84 (t, J ¼ 5.5 Hz, 8H), 3.77
(t, J ¼ 6.2 Hz, 4H), 1.58 (dd, J ¼ 18.3, 10.7 Hz, 12H), 1.33
(dd, J ¼ 14.8, 7.5 Hz, 12H), 0.99–0.76 (m, 18H). 13C NMR
(100 MHz, CDCl3) d 150.95, 150.07, 150.04, 132.80, 130.86,
127.80, 127.56, 117.57, 117.28, 116.59, 115.67, 108.29,
106.68, 69.50, 69.37, 39.30, 31.67, 31.64, 31.60, 19.31,
19.23, 13.83. m/z (MALDI-TOF) 950.592; [MþH]þ requires
950.659.
Compound 1h (2.20 g, 2.5 mmol), pyrrole (28 mL, 0.4 mol),
and InCl3 (111 mg, 0.5 mmol) were reacted under an argon
atmosphere at 508C for 30 min. The reaction was quenched with
powdered NaOH (0.8 g, 20 mmol) and stirring for 45 min before
filtering. Excess pyrrole was removed by distillation under
reduced pressure, and the resulting solid was treated with
hexanes (20 mL). The solvent was removed under reduced
pressure. The crude product was purified by column chroma-
tography on silica gel (hexane/CH2Cl2/ethyl acetate ¼ 4 : 2 : 1)
to afford the title compound as a dark green solid (2.71 g, 97 %).
M.p. 124–1268C. 1H NMR (400 MHz, CDCl3) d: 8.24 (brs, 4H),
7.43 (s, 4H), 7.16 (s, 2H), 7.13 (s, 2H), 6.72 (s, 2H), 6.68 (s, 4H),
6.14 (s, 4H), 5.95 (s, 4H), 5.71 (s, 2H), 4.03 (s, 4H), 3.90 (m, 8H),
1.78 (m, 8H), 1.61 (m, 16H), 1.33 (m, 16H), 1.06–0.80 (m, 18H);
13C NMR (100 MHz, CDCl3) d 151.25, 150.81, 132.61, 131.70,
127.66, 127.08, 123.66, 123.48, 116.74, 115.22, 111.30, 110.94,
108.47, 106.80, 69.74, 69.54, 69.50, 39.21, 32.01, 31.72, 29.72,
29.58, 29.45, 26.40, 22.79, 19.61, 19.36, 14.19, 14.09, 13.98;
m/z (MALDI-TOF) 1114.730; [MþH]þ requires 1114.749.
2,5-Bis(octyloxy)-1,4-bis{[(2,5-bis(octyloxy)-4-
(dipyrromethan-5-yl)]phenylenevinylene} benzene (3g)
Compound 1 g (1.02 g, 1.0 mmol), pyrrole (11.2 mL,
160 mmol), and InCl3 (45 mg, 0.2 mmol) were reacted under
an argon atmosphere at 508C for 30 min. The reaction was
quenched with powdered NaOH (0.4 g, 10 mmol) and stirring
for 45 min before filtering. Excess pyrrole was removed by
distillation under reduced pressure, and the resulting solid was
treated with hexanes (20 mL). The solvent was removed under
reduced pressure. The crude product was purified by column
chromatography on silica gel (hexane/CH2Cl2/ethyl acetate ¼
4 : 2 : 1) to afford the title compound as a dark green solid (1.18 g,
4,40-Oxybis(phenyldipyrromethane) (3i)
4,40-Oxydibenzaldehyde (565 mg, 2.5 mmol) was dissolved
in dry pyrrole (28 mL, 0.4 mol) and flushed with argon for
10 min. InCl3 (111 mg, 0.5 mmol) was added, and the reaction
was allowed to proceed for 30 min before quenching with
powdered NaOH (0.8 g, 20 mmol). The mixture was stirred for
45 min and then filtered. Excess pyrrole was removed by
distillation under reduced pressure and the resulting yellow
solid was treated with hexanes (10 mL). The solvent was
removed under reduced pressure, and the residue was purified
by column chromatography on silica gel (eluted with CH2Cl2) to
afford a pale yellow solid (1.04 g, 91 %). M.p. 74–778C.
1H NMR (400 MHz, CDCl3) d 7.95 (brs, 4H), 7.21–7.02
(m, 4H), 6.94 (t, J ¼ 7.9 Hz, 4H), 6.70 (s, 4H), 6.16 (d, J ¼
2.6 Hz, 4H), 5.92 (s, 4H), 5.46 (s, 2H); 13C NMR (100 MHz,
CDCl3) d 155.98, 137.06, 132.53, 129.59, 118.79, 117.25,
108.34, 107.18, 43.20; m/z (MALDI-TOF) 457.189; [MþH]þ
requires 458.210.
1
94 %). M.p. 143–1468C. H NMR (400 MHz, CDCl3) d: 8.25
(s, 4H), 7.42 (s, 4H), 7.16 (s, 2H), 7.13 (s, 2H), 6.72 (s, 2H), 6.68
(s, 4H), 6.14 (d, J ¼ 2.7 Hz, 4H), 5.95 (s, 4H), 5.70 (s, 2H), 4.03
(t, J ¼ 6.2 Hz, 4H), 3.88 (dt, J ¼ 16.2, 5.1 Hz, 8H), 1.91–1.69 (m,
12H), 1.68–1.42 (m, 12H), 1.29 (s, 36H), 0.87 (t, J ¼ 7.1 Hz,
18H). 13C NMR (100 MHz, CDCl3) d 151.34, 150.96, 150.79,
132.59, 131.67, 128.21, 127.12, 123.72, 123.52, 116.69, 115.21,
111.31, 110.98, 108.44, 106.76, 69.85, 69.76, 39.25, 31.97,
31.94, 29.72, 29.26, 29.24, 29.19, 26.35, 26.26, 26.11, 22.73,